Apria, Inc.

Delisted

CIK 0001735803Non-AcceleratedServices-Home Health Care ServicesDelawareFY ends Dec 31

Period

FY 2021

Revenue

$1.15B

Net Income

$64.88M

Total Assets

$775.43M

Equity

$39.73M

Shares Out

35.74M

Op. Cash Flow

$212.00M

Business

Apria, Inc. is a former operating company in Home Health Care Services, incorporated in Delaware. Securities are no longer actively traded on a major U.S. exchange.

Auto-generated from company profile

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31
TOTAL NET REVENUES	1,145	1,109	1,089
Product and supply costs	206	193	206
Patient equipment depreciation	101	101	97
Home respiratory therapists costs	16	17	20
Other	18	17	18
TOTAL COST OF NET REVENUES	341	328	341
Selling, distribution and administrative	707	709	721
TOTAL COSTS AND EXPENSES	1,048	1,038	1,061
OPERATING INCOME	97	71	27
Interest expense and other	12	6	5
Interest income and other	−254,000	−498,000	−1
Gain from derecognition of nonfinancial asset	−4	—	—
INCOME BEFORE INCOME TAXES	90	65	24
Income tax expense	24	19	8
Loss from equity method investment	791,000	—	—
NET INCOME	65	46	16
Weighted average shares outstanding - basic	35	—	—
Weighted average shares outstanding - diluted	38	—	—
Net income per common share - basic	1.79	—	—
Net income per common share - diluted	1.66	—	—

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31
Cash and cash equivalents	220	195	—	—
Accounts receivable	82	75	—	—
Inventories	9	7	—	—
Prepaid expenses and other current assets	23	24	—	—
TOTAL CURRENT ASSETS	333	301	—	—
NONCURRENT RESTRICTED CASH	515,000	—	—	—
PATIENT EQUIPMENT, less accumulated depreciation of $366,126 and $356,888 as of December 31, 2021 and December 31, 2020, respectively	222	224	—	—
PROPERTY, EQUIPMENT AND IMPROVEMENTS, NET	21	25	—	—
INTANGIBLE ASSETS, NET	72	61	—	—
OPERATING LEASE RIGHT-OF-USE ASSETS	72	58	—	—
GOODWILL	29	—	—	—
EQUITY METHOD INVESTMENT	3	—	—	—
DEFERRED INCOME TAXES, NET	4	18	—	—
NOTE RECEIVABLE, RELATED PARTY (Note 12)	2	—	—	—
OTHER ASSETS	17	17	—	—
TOTAL ASSETS	775	705	—	—
Accounts payable	133	117	—	—
Accrued payroll and related taxes and benefits	52	56	—	—
Other accrued liabilities	33	34	—	—
Deferred revenue	28	26	—	—
Current portion of operating lease liabilities	23	24	—	—
Current portion of long-term debt	36	21	—	—
TOTAL CURRENT LIABILITIES	307	277	—	—
LONG-TERM DEBT, less current portion	341	376	—	—
OPERATING LEASE LIABILITIES, less current portion	48	35	—	—
DEFERRED INCOME TAXES, NET	7	—	—	—
OTHER NONCURRENT LIABILITIES	32	43	—	—
TOTAL LIABILITIES	736	731	—	—
COMMITMENTS AND CONTINGENCIES (Note 10)	—	—	—	—
Preferred stock, $0.01 par value: 100,000,000 authorized; no shares issued as of December 31, 2021 and February 10, 2021 (Note 1)	—	—	—	—
Common stock, $0.01 par value: 1,000,000,000 authorized; 35,521,594 and 35,210,915 shares issued and outstanding as of December 31, 2021 and February 10, 2021, respectively (Note 1)	355,000	—	—	—
Additional paid-in capital	955	954	—	—
Accumulated deficit	−916	−980	—	—
TOTAL STOCKHOLDERS' EQUITY (DEFICIT)	40	−26	135	285
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	775	705	—	—

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31
Depreciation	113	115	111
Amortization of intangible assets	2	600,000	600,000
Non-cash lease expense	27	27	28
Deferred income taxes	21	16	9
Stock-based compensation	8	3	9
Amortization of deferred debt issuance costs	1	1	1
Loss on sale and dispositions of patient equipment and other	7	4	4
Loss from unconsolidated joint venture	791,000	—	—
Accounts receivable	−7	9	13
Inventories	356,000	169,000	315,000
Prepaid expenses and other assets	3	−11	2
Accounts payable	17	−3	−15
Accrued payroll and related taxes and benefits	−3	7	8
Operating lease liabilities	−29	−25	−29
Income taxes payable	59,000	−240,000	−1
Deferred revenue	983,000	961,000	−610,000
Legal reserve	1	−12	—
Accrued expenses	−13	17	6
NET CASH PROVIDED BY OPERATING ACTIVITIES	212	197	162
Purchases of patient equipment and property, equipment and improvements	−119	−109	−114
Proceeds from sale of patient equipment and other	17	17	22
Preferred distribution from equity method investment	3	—	—
Issuance of note receivable, related party	−2	—	—
Cash paid for acquisitions, net of cash received	−43	—	—
NET CASH USED IN INVESTING ACTIVITIES	−144	−92	−93
Payments on asset financing	−15	−23	−31
Proceeds from revolving credit facility	—	—	5
Disbursements to revolving credit facility	—	—	−5
Borrowings on debt	—	260	150
Payments on debt	−21	−9	—
Payments on deferred financing costs	—	−3	−3
Payments of dividend	—	−210	−175
Distribution payments	−589,000	—	—
Payments for tax withholdings from equity-based compensation activity	−6	—	—
NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES	−43	16	−59
NET INCREASE IN CASH AND CASH EQUIVALENTS	25	121	10
Unpaid purchases	51	55	60
Unpaid purchases, extended payment terms	9	16	24
Non-cash contribution of software and other intellectual property	9	—	—

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro